HopeStage
Back to all studies
RecruitingNCT06144177

Star projector, midazolam or parent presence for young children’s surgery anxiety

About this titleRead the official source — NCT06144177
Medication studyAges 2–6United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 2 years to 6 years.

Listed locations
CharlestonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 16, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
240
Sponsor
Medical University of South Carolina
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 2 Years to 6 Years
Official registry ID
NCT06144177
Official title
Show the full official title

Induction in the Dark: a Prospective Randomized Control Trial for Perioperative Pediatric Anxiety

Recruitment & locations

Currently recruiting

Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Does this study involve medication?

Yes. The study involves medication, including Preoperative midazolam.

Who can participate?

Listed age limits: 2 years to 6 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies